Diagnos Laboratorium Utama Tbk. vs Bangun Karya Perkasa Jaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Bangun Karya Perkasa Jaya Tbk. trades at Rp60 (market cap 98.17B, 127.97M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.2× Bangun Karya Perkasa Jaya Tbk.'s market cap, and Bangun Karya Perkasa Jaya Tbk. is more actively traded (127.97M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | KRYA | |
|---|---|---|
Market Cap | 310.75B | 98.17B |
Volume | 963.6K | 127.97M |
Lot | 9.64K | 1.28M |
Turnover | 217.67M | 7.94B |
Average Price | 225.89 | 62.04 |
Value | 217.67M | 7.94B |
Indicative Equilibrium Price | 226 | 60 |
Indicative Equilibrium Volume | 1K | 19.78K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Bangun Karya Perkasa Jaya Tbk (the "Entity") was established based on a Notarial Deed No. 2 dated January 7, 2007, of Ranti Nursukma H, S.H., Notary in Surabaya. The Entity started commercial operations in 2007.
Read more on KRYA →